NEW YORK STATE COMMON RETIREMENT FUND - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 119 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$0
-100.0%
173
-36.6%
0.00%
Q1 2024$10.0%2730.0%0.00%
Q4 2023$10.0%273
-10.2%
0.00%
Q3 2023$1
-98.6%
304
-97.2%
0.00%
Q2 2023$73
-64.0%
10,951
+0.6%
0.00%
Q1 2023$203
-18.5%
10,885
-5.9%
0.00%
Q4 2022$249
-99.8%
11,571
-0.1%
0.00%
Q3 2022$137,000
-9.9%
11,582
+0.5%
0.00%
Q2 2022$152,000
-36.9%
11,525
-0.2%
0.00%
Q1 2022$241,000
+2.6%
11,549
-0.2%
0.00%
Q4 2021$235,000
-33.0%
11,574
+0.2%
0.00%
Q3 2021$351,000
-21.1%
11,551
-24.6%
0.00%
Q2 2021$445,000
-53.3%
15,310
-30.6%
0.00%
-100.0%
Q1 2021$953,000
+73.3%
22,070
+85.5%
0.00%0.0%
Q4 2020$550,000
+30.6%
11,900
+22.7%
0.00%0.0%
Q3 2020$421,000
-18.1%
9,7000.0%0.00%0.0%
Q2 2020$514,000
+264.5%
9,700
+54.0%
0.00%
Q1 2020$141,000
+5.2%
6,300
-31.5%
0.00%
Q4 2019$134,000
+106.2%
9,2000.0%0.00%
Q3 2019$65,000
-35.6%
9,2000.0%0.00%
Q2 2019$101,0009,2000.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Logos Global Management LP 430,000$19,866,0001.70%
APIS CAPITAL ADVISORS, LLC 20,000$924,0000.89%
Avidity Partners Management LP 547,000$25,271,0000.82%
Knoll Capital Management, LLC 20,000$924,0000.63%
Artemis Investment Management LLP 1,013,448$46,839,0000.49%
AlphaCentric Advisors LLC 25,000$1,155,0000.48%
First Light Asset Management, LLC 94,202$4,352,0000.32%
Ikarian Capital, LLC 150,000$6,930,0000.31%
Longitude (Cayman) Ltd. 8,000$370,0000.18%
AllSquare Wealth Management LLC 5,490$254,0000.17%
View complete list of BIOXCEL THERAPEUTICS INC shareholders